论文部分内容阅读
目的观察低分子肝素治疗短暂性脑缺血发作(TIA)的疗效和安全性。方法120例TIA患者分为治疗组(低分子肝素加常规药物治疗60例)与对照组(胞二磷胆碱加血塞通加阿司匹林60例)进行疗效比较。结果治疗后治疗组和对照组治愈率分别为58.3%和30%(P<0.05),总有效率分别为88.3%和58.3%(P<0.05)。结论低分子肝素治疗短暂性脑缺血发作可疗效显著,安全可靠,值得临床推广。
Objective To observe the efficacy and safety of low molecular weight heparin in the treatment of transient ischemic attack (TIA). Methods 120 cases of TIA patients were divided into treatment group (low molecular weight heparin and conventional drug treatment in 60 cases) and control group (citicoline plus Xuesaitong plus aspirin in 60 cases) were compared. Results After treatment, the cure rates in the treatment group and the control group were 58.3% and 30%, respectively (P <0.05). The total effective rates were 88.3% and 58.3%, respectively (P <0.05). Conclusion Low molecular weight heparin therapy for transient ischemic attack can be effective, safe and reliable, worthy of clinical promotion.